Neurogene Company
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Industry:
Gene Therapy
Investment Stage:
N/A
Technology:
Neurological Disorders
Headquarters:
New York, New York, United States
Founded Date:
2018
Investor Type:
N/A
Funding Status:
Early Stage Venture
Estimated Revenue:
$10M to $50M
Number Of Exists:
N/A
Employee Number:
11-50